Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy tissue, often affecting the skin, joints, kidneys and nervous system.

During a roundtable discussion at the Cleveland Clinic Basic and Clinical Immunology for the Busy Clinician ... that have no prior memory of causing lupus.” The critical question is how best ...

according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium. Black patients, particularly women, have died from systemic lupus erythematosus at disproportionately ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

Rheumatoid arthritis (RA) and lupus both cause joint pain and stiffness. Despite some similarities, it’s easy for doctors to distinguish them. RA has more debilitating effects on the joints.

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

The Dren Bio drug is currently being evaluated in two Phase 1 studies, one in healthy volunteers and the other in a range of autoimmune diseases, such as lupus, Sjogren’s syndrome ...